A detailed history of Assenagon Asset Management S.A. transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 730,820 shares of VNDA stock, worth $3.73 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
730,820
Previous 1,587,717 53.97%
Holding current value
$3.73 Million
Previous $6.7 Million 55.18%
% of portfolio
0.01%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

SELL
$3.47 - $4.61 $2.97 Million - $3.95 Million
-856,897 Reduced 53.97%
730,820 $3 Million
Q4 2022

Jan 12, 2023

SELL
$6.87 - $10.96 $14,722 - $23,487
-2,143 Reduced 0.13%
1,587,717 $11.7 Million
Q3 2022

Oct 27, 2022

SELL
$9.44 - $11.76 $8.84 Million - $11 Million
-936,620 Reduced 37.07%
1,589,860 $15.7 Million
Q2 2022

Jul 27, 2022

BUY
$9.31 - $11.84 $11.1 Million - $14.2 Million
1,195,768 Added 89.86%
2,526,480 $27.5 Million
Q1 2022

Apr 25, 2022

BUY
$10.84 - $16.55 $9.52 Million - $14.5 Million
878,492 Added 194.26%
1,330,712 $15.1 Million
Q4 2021

Feb 01, 2022

BUY
$15.69 - $21.14 $5.73 Million - $7.72 Million
365,075 Added 418.93%
452,220 $7.1 Million
Q3 2021

Oct 19, 2021

BUY
$15.35 - $21.27 $234,394 - $324,792
15,270 Added 21.25%
87,145 $1.49 Million
Q2 2021

Jul 15, 2021

SELL
$15.71 - $21.51 $4.96 Million - $6.79 Million
-315,730 Reduced 81.46%
71,875 $1.55 Million
Q1 2021

Apr 26, 2021

SELL
$13.42 - $20.28 $1.52 Million - $2.3 Million
-113,563 Reduced 22.66%
387,605 $5.82 Million
Q4 2020

Feb 01, 2021

BUY
$9.77 - $13.81 $390,643 - $552,179
39,984 Added 8.67%
501,168 $6.59 Million
Q3 2020

Oct 07, 2020

SELL
$9.32 - $12.02 $60,990 - $78,658
-6,544 Reduced 1.4%
461,184 $4.46 Million
Q2 2020

Jul 21, 2020

BUY
$9.66 - $12.02 $4.52 Million - $5.62 Million
467,728 New
467,728 $5.35 Million

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $289M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.